Calcifediol in the Treatment of SARS-CoV-2 Disease (COVID-19). (NCT06279910) | Clinical Trial Compass
CompletedNot Applicable
Calcifediol in the Treatment of SARS-CoV-2 Disease (COVID-19).
Spain230 participantsStarted 2024-02-21
Plain-language summary
Descriptive, retrospective, observational, anonymous, study to evaluate the potential effect of incorporating calcifediol into the therapeutic protocol of patients hospitalized for COVID-19 on mortality and other outcome variables, such as admission to the Intensive Care Unit (ICU), to "Complejo Hospitalario Universitario de Albacete" (CHUA). Albacete (Spain)", based on the files of the MXXI medical records, Information System of the Laboratory (ISL) and Pharmacy.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. Admitted to the hospital CHUA
. Meet the SARS-CoV-2 diagnostic criteria with positive PCR
. They have completed at least the first dose of Calcifediol within the first 72 hours after admission, (according to protocol).
Exclusion criteria
. Patients who do not receive the full first dose of Calcifediol within the first 72 hours.
. Patients for whom electronic medical record data cannot be collected.
. Patients with other serious intercurrent diseases (eg advanced oncological pathology).
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Measure mortality by differentiating groups: calcifediol yes/no.
Timeframe: 02/21/2024 to 04/25/2024
2
Measure the need for ICU admission by differentiating the groups calcifediol yes/no.
Timeframe: 02/21/2024 to 04/25/2024
Trial details
NCT IDNCT06279910
SponsorComplejo Hospitalario Universitario de Albacete